📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
3 articles
AVG GRADE
NEUTRAL
score: 0.33
SENTIMENT
NEUTRAL
TOTAL VIEWS
21
ARDX Latest News & AI Sentiment Analysis
3 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 6 ARTICLES
Ardelyx Q2: Strong Demand, But Payer Friction Clouds The Story (NASDAQ:ARDX)
Ardelyx (ARDX) demonstrated operational momentum in Q2 with 31% year-over-year revenue growth, signaling underlying demand for its...
Ardelyx signals lower 2026 IBSRELA guidance to $350M-$370M while revising 2026 opex to below $500M (NASDAQ:ARDX)
Ardelyx (ARDX) reported record Q2 2026 revenue of $118M but simultaneously issued a significant guidance reduction for IBSRELA sales,...
Ardelyx, Inc. (ARDX) Q2 2026 Earnings Call Transcript
Ardelyx (ARDX) released Q2 2026 earnings results via earnings call transcript, providing routine disclosure of financial and operational...
Ardelyx Stock: The Market Is Right To Discount This Revenue Growth (NASDAQ:ARDX)
Ardelyx (ARDX) faces structural headwinds that justify current market valuation discounts. The company's flagship product Xphozah...
What’s Fueling Optimism Around Ardelyx, Inc. (ARDX)’s Sales and Pipeline?
Ardelyx (ARDX) received a new Buy rating and $16 price target from Ladenburg Thal on June 16, reflecting renewed institutional...
Zydus Lifesciences shares in focus as firm acquires US-based Assertio Holdings for $166 million
Zydus Lifesciences has completed its $166.4 million acquisition of Assertio Holdings, a US-based pharmaceutical firm, through a cash...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice